23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
The fight against COVID19 | - | - | - | - |
^GSPC | +0.51% | +1.04% | +26.02% | +5506.54% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 149.85 | +0.90 | +0.60% | 4:00 pm GMT-4 | 6.38M | 7.59M | 360.64B |
ABBV | AbbVie Inc. | 160.4 | -0.05 | -0.03% | 4:00 pm GMT-4 | 3.44M | 5.69M | 283.25B |
PFE | Pfizer Inc. | 28.18 | +0.33 | +1.18% | 4:00 pm GMT-4 | 46.62M | 42.71M | 159.68B |
SNY | Sanofi | 48.69 | +0.63 | +1.31% | 4:00 pm GMT-4 | 1.12M | 2.01M | 125.04B |
REGN | Regeneron Pharmaceuticals, Inc. | 968 | +12.24 | +1.28% | 4:00 pm GMT-4 | 274.62k | 460.69k | 106.66B |
GSK | GSK plc | 44.67 | +0.53 | +1.20% | 4:00 pm GMT-4 | 2.78M | 3.34M | 91.89B |
GILD | Gilead Sciences, Inc. | 64.58 | -0.34 | -0.52% | 4:00 pm GMT-4 | 6.02M | 7.18M | 80.46B |
MRNA | Moderna, Inc. | 122.69 | +0.80 | +0.66% | 4:00 pm GMT-4 | 3.36M | 3.87M | 47.02B |
TAK | Takeda Pharmaceutical Company Limited | 13.37 | +0.31 | +2.37% | 4:00 pm GMT-4 | 2.94M | 1.67M | 41.96B |
BNTX | BioNTech SE | 92.06 | +1.93 | +2.14% | 4:00 pm GMT-4 | 581.56k | 602.85k | 22.19B |
VIR | Vir Biotechnology, Inc. | 9.56 | +0.02 | +0.21% | 4:00 pm GMT-4 | 683.17k | 1.04M | 1.30B |
NVAX | Novavax, Inc. | 4.47 | - | - | 4:00 pm GMT-4 | 4.45M | 6.83M | 627.60M |
INO | Inovio Pharmaceuticals, Inc. | 11.18 | +0.18 | +1.64% | 4:00 pm GMT-4 | 121.24k | 452.69k | 289.64M |
U.S. stock index futures rose on Friday, as investors eagerly awaited comments from Federal Reserve officials to get more clarity on rate cuts, after economic data this week supported bets of monetary policy easing. Wall Street indexes were inching closer to record highs following a selloff last month, as a slew of economic data pointed to a cooling labor market, raising expectations that the Fed will cut borrowing costs more than once this year.
(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Most Read from BloombergBiden Set to Impose Tariffs on China EVs, Strategic SectorsAckman Scolded Over DEI Views at Closed-Door Milken SessionApple Apologizes for iPad Pro Ad, Scraps Plan to Air It on TVMarjorie Taylor Greene Finally Got What She Deserved: Defeat‘Seriously Underwater’ Home Mortgages Tick Up Across the US
Key Insights Institutions' substantial holdings in Regeneron Pharmaceuticals implies that they have significant...